Page 109 - 北京京煤集团总医院第十一届·2023学术年会论文集
P. 109

北京京煤集团总医院                                                          第十一届·2023 学术年会论文集

                   酸氢钠注射液碱化尿液可以减少 CIN 发生,本研究应用了更便捷、副作用更小的碳酸氢钠

                   片联合水化治疗。最终研究结果是该方案在患者围手术期肾功能改善、预防造影剂肾病发
                   生方面起到了很好的作用。限于单中心、样本量较少等不足,希望未来进行多中心合作、

                   大样本的研究进一步证实。
                                                        参考文献

                   [1]  廖志波  廖学渊  吴勇林.冠脉介入治疗患者造影剂肾病发病率及相关危险因素分析[J].心
                   血管病防治知识,2022,12 (26):10-13.

                   [2]  Abe M, Morimoto  T,   Nakagawa  Y , et al. Impact of transient or  persistent  contrast-induced
                   nephropathy on long-term   mortality after elective percutaneous coronary intervention [J]. Am J
                   Cardiol , 2017, 120 (12) :   2146-53.

                   [3] Wi J,Ko Y G,Kim J S,et al.  Impact of contrast-induced acute kidney injury with transient
                   or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction

                   undergoing percutaneous coronary intervention [J].Heart,2011,97(21):1753-1757.
                   [4] Chalikias G,Drosos I,Tziakas D N. Contrast-induced acute kidney injury: an update [J].

                   Cardiovasc Drugs Ther,2016,30(2):215-228.
                   [5]  余雅,杨定平卢远航等.  经皮冠状动脉介入术后造影剂肾病的发生率及危险因素分析[J]

                   医学综述,2021,27(18): 3706-3710.
                   [6]  孙晓琳,  董得时,  杨世磊.  碘造影剂肾病的损伤机制和预防策略[J].  中国现代应用药学,

                   2022, 39(2): 261-268.
                   [7] Huber W, Huber T, Baum S, et al.Sodium bicarbonate prevents contrast-induced nephropathy in
                   addition to theophylline:a randomized controlled trial[J].Medicine,2016,95(21): e3720.

                   [8] Sato A, Aonuma K, Watanabe M, et al. Association of contrast-induced   nephropathy with risk
                   of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study[J]. Int

                   Cardiol, 2017, 227(13): 424-9.
                   [9]  Liu YH, Liu Y , Zhou YL, et al. Comparison of different risk scores  for  predicting  contrast
                   induced nephropathy and   outcomes after primary percutaneous coronary intervention in patients
                   with ST elevation myocardial infarction[J]. Am J Cardiol, 2016, 117(12):1896-903.
                   [10] Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and

                   cardiac interventions[J]. Heart, 2016,102(8): 638-48.
                   [11]  贺世豪,李瑾.对比剂肾病发病机制、危险因素及预防措施研究进展[J].  新乡医学院学

                   报,2022,39(11):1096-1100.
                   [12]  Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS  guidelines  on  myocardial
                   revascularization[J]. Eur Heart J, 2019,40(2): 87-165.

                   [13] Dong Y,Zhang B,Liang L,et al.How strong is the evidence for sodium bicarbonate to prevent
                   contrast  -  induced  acute  kidney  injury  after  coronary  angiography  and  percutaneous  coronary

                   intervention[J].Medicine,2016,95(7): e2715.


                                                          - 105 -
   104   105   106   107   108   109   110   111   112   113   114